Total Payments
$1,310
2024 Payments
$146.64
Companies
25
Transactions
54
Medicare Patients
250
Medicare Billing
$35,293
Payment Breakdown by Category
Food & Beverage$1,310 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,310 | 54 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Focal Therapeutics, Inc. | $378.74 | 2 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $153.41 | 3 | $0 (2018) |
| INSYS Therapeutics Inc | $118.00 | 7 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $114.16 | 7 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $75.64 | 5 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $64.84 | 4 | $0 (2018) |
| Coherus Biosciences Inc. | $41.06 | 2 | $0 (2022) |
| GENZYME CORPORATION | $36.20 | 2 | $0 (2018) |
| EISAI INC. | $34.64 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $34.61 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $146.64 | 8 | Novartis Pharmaceuticals Corporation ($58.04) |
| 2022 | $131.14 | 8 | Novartis Pharmaceuticals Corporation ($44.86) |
| 2021 | $52.89 | 3 | Eisai Inc. ($19.78) |
| 2019 | $27.77 | 2 | Merck Sharp & Dohme Corporation ($16.51) |
| 2018 | $473.38 | 15 | Focal Therapeutics, Inc. ($156.02) |
| 2017 | $478.65 | 18 | Focal Therapeutics, Inc. ($222.72) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Oncology | ||||||
| 10/17/2024 | SERVIER PHARMACEUTICALS LLC | Voranigo (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Oncology | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Oncology | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Oncology | ||||||
| 05/14/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/08/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 05/02/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 11/03/2022 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 11/01/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.01 | General |
| Category: Oncology | ||||||
| 10/18/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $14.86 | General |
| Category: Oncology | ||||||
| 08/29/2022 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 07/05/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: HORMONE THERAPY | ||||||
| 02/24/2022 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: ONCOLOGY | ||||||
| 02/15/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: ONCOLOGY | ||||||
| 01/13/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: ONCOLOGY | ||||||
| 12/30/2021 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $19.78 | General |
| Category: Oncology | ||||||
| 12/22/2021 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 11/22/2021 | Genentech USA, Inc. | Alecensa (Biological), TECENTRIQ, ROZLYTREK | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: BioOncology | ||||||
| 12/13/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: ONCOLOGY | ||||||
| 03/18/2019 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug), KISQALI | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: ONCOLOGY | ||||||
| 12/21/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 11/02/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 160 | 409 | $93,592 | $26,267 |
| 2022 | 4 | 90 | 215 | $36,837 | $9,027 |
Total Patients
250
Total Services
624
Medicare Billing
$35,293
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 12 | 38 | $20,596 | $5,421 | 26.3% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2023 | 12 | 154 | $20,020 | $5,194 | 25.9% |
| 77301 | High precision radiation therapy planning | Facility | 2023 | 11 | 11 | $13,321 | $3,173 | 23.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 20 | 20 | $6,005 | $2,683 | 44.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 28 | 36 | $3,690 | $1,768 | 47.9% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 15 | 15 | $7,230 | $1,764 | 24.4% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2023 | 11 | 11 | $7,150 | $1,702 | 23.8% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 12 | 41 | $5,330 | $1,383 | 25.9% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 13 | 48 | $4,512 | $1,088 | 24.1% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 15 | 24 | $4,176 | $1,048 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 11 | $1,562 | $1,041 | 66.7% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2022 | 11 | 20 | $10,840 | $2,844 | 26.2% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2022 | 30 | 80 | $10,545 | $2,725 | 25.8% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2022 | 11 | 50 | $6,500 | $1,691 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 24 | 26 | $6,528 | $1,162 | 17.8% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2022 | 14 | 39 | $2,424 | $604.21 | 24.9% |
About Dr. Julia Compton, MD
Dr. Julia Compton, MD is a Radiation Oncology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2009. The National Provider Identifier (NPI) number assigned to this provider is 1942435797.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Julia Compton, MD has received a total of $1,310 in payments from pharmaceutical and medical device companies, with $146.64 received in 2024. These payments were reported across 54 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,310).
As a Medicare-enrolled provider, Compton has provided services to 250 Medicare beneficiaries, totaling 624 services with total Medicare billing of $35,293. Data is available for 2 years (2022–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Indianapolis, IN
- Active Since 05/22/2009
- Last Updated 12/18/2014
- Taxonomy Code 2085R0001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942435797
Products in Payments
- BioZorb (Device) $378.74
- Xofigo (Drug) $153.41
- SUBSYS (Drug) $78.72
- KEYTRUDA (Biological) $75.64
- KISQALI (Drug) $64.95
- XARELTO (Drug) $64.84
- Udenyca (Biological) $41.06
- SYNDROS (Drug) $39.28
- TAXOTERE (Drug) $36.20
- Lenvima (Drug) $34.64
- TAGRISSO (Drug) $34.61
- SpaceOAR VUE System - 10mL (Device) $27.56
- Voranigo (Drug) $24.15
- PLUVICTO (Drug) $20.19
- OPDIVO (Biological) $18.01
- MEKINIST (Drug) $17.76
- ORGOVYX (Drug) $17.76
- CABOMETYX (Drug) $17.12
- LIBTAYO (Biological) $16.81
- Gelclair (Device) $15.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Radiation Oncology Doctors in Indianapolis
Robert Liebross, Md, MD
Radiation Oncology — Payments: $36,628
Radiation Oncology $36,628
Dr. Michael Eaton, M.d, M.D
Radiation Oncology — Payments: $10,814
Radiation Oncology $10,814
Dr. Peter Garrett, Md, MD
Radiation Oncology — Payments: $9,990
Radiation Oncology $9,990
Mr. Alexander Yeh, Md, MD
Radiation Oncology — Payments: $5,533
Radiation Oncology $5,533
Dr. John Cox, M.d, M.D
Radiation Oncology — Payments: $5,091
Radiation Oncology $5,091
Christopher Leagre, Md, MD
Radiation Oncology — Payments: $2,877
Radiation Oncology $2,877